CLINICO- DEMOGRAPHIC PROFILE OF HEMATO-ONCOLOGY PATIENTS VISITING A TERTIARY CANCER CENTRE IN NORTH- EAST INDIA

Dr Bhargab Jyoti Saikia, Dr Satya Sadhan Sarangi, Dr Munlima Hazarika, Dr Partha S Roy, Dr Nizara Baishya

Abstract


Background: The pattern and prole of diagnosed hemato-oncological (HO) cancers patients are necessary to
understand in order to develop better management strategies.
Methods: Retrospective descriptive study of patients diagnosed with Hematological malignancies between January 2010 and December 2017
visiting Dr B. Borooah cancer institute, Assam The FAB (French-American-British) classication system has been taken into account in the
analysis of myeloid and lymphoid neoplasms.
Results: In this study, there were 2598 cases of HO cases registered at BBCI over 8 years with a Male: Female ratio of 2.06:1. Out of these, only
1252 cases were treated. The most common diagnosis was Non Hodgkin lymphoma. Dropout rate was minimum in 2011 and maximum in 2017.
Of the treated cases, 45 % of population were alive whereas one fourth of the cases were dead.
Conclusions: The dropout rate of cases are high, which remains a concern and merits effective management plan.


Keywords


Hemato- Oncology, Dropout, Demographic Prole, North east India

Full Text:

PDF

References


Bennett, J.H. (1845). Case of hypertrophy of the spleen and liver in which death took place from suppuration of the blood. Edinburgh Medical and Surgical Journal, 64, 413– 423.

Solly, S. (1844). Remarks on the pathology of mollities ossium; with cases. Medico-Chirurgical Transactions, 27, 435– 461, 498-3–498-8.

Gall, E.A., & Mallory, T.B. (1942). Malignant lymphoma: A clinico-pathologic survey of 618 cases. American Journal of Pathology, 18, 381–429.

Lichtman, M.A. (2008). Battling the hematological malignancies: The 200 years’ war. Oncologist, 13, 126–138. doi:10.1634/theoncologist.2007-0228.

Bain BJ, Catovsky D. The leukaemic phase of non-Hodgkin’s lymphoma. J Clin Pathol. 1995;48(3):189–93.

Leclair SJ, Rodak BF. The new WHO nomenclature: lymphoid neoplasms. Clin Lab Sci. 2002;15(1):55–9.

Rodak BF, Leclair SJ. The new WHO nomenclature: Introduction and myeloid meoplasms. Clin Lab Sci. 2002;15(1):44–54.

Bouchbika Z, Haddad H, Benchakroun N, Kotbi S, Megrini A, Bourezgui H, et al. Cancer incidence in Morocco: report from Casablanca registry 2005-2007. Pan Afr Med J. 2013;16(1):31.

Pearce MS, Parker L. Childhood cancer registrations in the developing world: still more boys than girls. Int J Cancer. 2001;91(3):402–6.

Elidrissi Errahhali, M., Elidrissi Errahhali, M., Boulouiz, R. et al. Distribution and features of hematological malignancies in Eastern Morocco: a retrospective multicenter study over 5 years. BMC Cancer 16, 159 (2016).

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014;136(5):E359–86.

Hazarika, Munlima & Mishra, Rakesh & Saikia, Bhargab & Bhuyan, Chidananda & Nyuthe, C & Sarma, Anupam & Kumar, Gaurav & Sutnaga, Cliffton & Kalita, Manoj & Roy, Partha. (2019). Causes of Treatment Abandonment of Pediatric Cancer Patients– Experience in a Regional Cancer Centre in North East India. Asian Pacific Journal of Cancer Prevention. 20. 1133-1137. 10.31557/APJCP.2019.20.4.1133.


Refbacks

  • There are currently no refbacks.